Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial
Hideki Ishikawa; Michihiro Mutoh; Yasushi Sato; Hisashi Doyama; Masahiro Tajika; Shinji Tanaka; Takahiro Horimatsu; Yoji Takeuchi; Hiroshi Kashida; Jun Tashiro; Yasumasa Ezoe; Takeshi Nakajima; Hiroaki Ikematsu; Shinichiro Hori; Sadao Suzuki; Takahiro Otani; Tetsuji Takayama; Yoshio Ohda; Kanae Mure; Keiji Wakabayashi; Toshiyuki Sakai
The Lancet Gastroenterology & Hepatology, Jun. 2021